CDT

SEC source: 0001753926-26-001698 · ownership.xml · derivative · entry 6

Regan Andrew · CIK 0001991325 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · By Corvus Capital Ltd.

Disclosed balance after: 0

Underlying: Common Stock · 5,436,830 shares

Expires not disclosed

F1 · shares: On July 30, 2026, Corvus Capital Limited ("Corvus") entered into that certain securities purchase agreement (the "Agreement") with CDT Equity Inc. (the "Issuer") and certain other investors of Sarborg Limited, a Cayman Islands Company ("Sarborg"), named therein, pursuant to which, on July 30, 2026, Corvus sold to the Issuer an aggregate of 120 shares of Sarborg (such shares the "Sarborg Shares") and the Issuer issued to Corvus as consideration for the Sarborg Shares pre-funded warrants (the "Pre-Funded Warrants") to purchase up to an aggregate of 5,436,830 shares of common stock, par value $0.0001 per share, of the Issuer (the "Common Stock"), at an exercise price of $0.0001 per share.

F2 · shares: The Pre-Funded Warrants include a "cashless" exercise provision, wherein the holder of the Pre-Funded Warrant is entitled to receive a number of shares of Common Stock generally equal to the quotient obtained by dividing the market price minus the exercise price divided by the market price (as further described in the Pre-Funded Warrant). The Pre-Funded Warrants became exercisable on August 28, 2026, following the receipt of stockholder approval for the issuance of the underlying Common Stock, and, on such date, Corvus exercised all of its Pre-Funded Warrants via cashless exercise and received 5,436,540 shares of Common Stock.

F3 · shares: These shares of Common Stock and Pre-Funded Warrants are owned of record by Corvus.

F7 · derivative.expiration_date: The Pre-Funded Warrants have been exercised in full.

F1 · derivative.underlying_shares: On July 30, 2026, Corvus Capital Limited ("Corvus") entered into that certain securities purchase agreement (the "Agreement") with CDT Equity Inc. (the "Issuer") and certain other investors of Sarborg Limited, a Cayman Islands Company ("Sarborg"), named therein, pursuant to which, on July 30, 2026, Corvus sold to the Issuer an aggregate of 120 shares of Sarborg (such shares the "Sarborg Shares") and the Issuer issued to Corvus as consideration for the Sarborg Shares pre-funded warrants (the "Pre-Funded Warrants") to purchase up to an aggregate of 5,436,830 shares of common stock, par value $0.0001 per share, of the Issuer (the "Common Stock"), at an exercise price of $0.0001 per share.

F2 · derivative.underlying_shares: The Pre-Funded Warrants include a "cashless" exercise provision, wherein the holder of the Pre-Funded Warrant is entitled to receive a number of shares of Common Stock generally equal to the quotient obtained by dividing the market price minus the exercise price divided by the market price (as further described in the Pre-Funded Warrant). The Pre-Funded Warrants became exercisable on August 28, 2026, following the receipt of stockholder approval for the issuance of the underlying Common Stock, and, on such date, Corvus exercised all of its Pre-Funded Warrants via cashless exercise and received 5,436,540 shares of Common Stock.

F3 · derivative.underlying_shares: These shares of Common Stock and Pre-Funded Warrants are owned of record by Corvus.

F1 · balance_after: On July 30, 2026, Corvus Capital Limited ("Corvus") entered into that certain securities purchase agreement (the "Agreement") with CDT Equity Inc. (the "Issuer") and certain other investors of Sarborg Limited, a Cayman Islands Company ("Sarborg"), named therein, pursuant to which, on July 30, 2026, Corvus sold to the Issuer an aggregate of 120 shares of Sarborg (such shares the "Sarborg Shares") and the Issuer issued to Corvus as consideration for the Sarborg Shares pre-funded warrants (the "Pre-Funded Warrants") to purchase up to an aggregate of 5,436,830 shares of common stock, par value $0.0001 per share, of the Issuer (the "Common Stock"), at an exercise price of $0.0001 per share.

F2 · balance_after: The Pre-Funded Warrants include a "cashless" exercise provision, wherein the holder of the Pre-Funded Warrant is entitled to receive a number of shares of Common Stock generally equal to the quotient obtained by dividing the market price minus the exercise price divided by the market price (as further described in the Pre-Funded Warrant). The Pre-Funded Warrants became exercisable on August 28, 2026, following the receipt of stockholder approval for the issuance of the underlying Common Stock, and, on such date, Corvus exercised all of its Pre-Funded Warrants via cashless exercise and received 5,436,540 shares of Common Stock.

F3 · balance_after: These shares of Common Stock and Pre-Funded Warrants are owned of record by Corvus.

F4 · ownership.nature: Corvus is the owner of 99.0% of the equity interests of Manoira Corporation ("Manoira") and, therefore, may also be deemed to beneficially own the shares of Common Stock held of record by Manoira. Dr. Andrew Regan is the sole director of Manoira and the Chief Executive Officer and sole shareholder of Corvus. By virtue of these relationships, Dr. Regan may be deemed to beneficially own the shares of Common Stock and Pre-Funded Warrants held of record by Manoira and Corvus. Each of Corvus and Dr. Regan disclaims any such beneficial ownership, except to the extent of its or his pecuniary interest therein.

SEC source: 0001753926-26-001698 · ownership.xml · nonDerivative · entry 2

Regan Andrew · CIK 0001991325 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · By Corvus Capital Ltd.

Disclosed balance after: 5,692,933

F1 · kind: On July 30, 2026, Corvus Capital Limited ("Corvus") entered into that certain securities purchase agreement (the "Agreement") with CDT Equity Inc. (the "Issuer") and certain other investors of Sarborg Limited, a Cayman Islands Company ("Sarborg"), named therein, pursuant to which, on July 30, 2026, Corvus sold to the Issuer an aggregate of 120 shares of Sarborg (such shares the "Sarborg Shares") and the Issuer issued to Corvus as consideration for the Sarborg Shares pre-funded warrants (the "Pre-Funded Warrants") to purchase up to an aggregate of 5,436,830 shares of common stock, par value $0.0001 per share, of the Issuer (the "Common Stock"), at an exercise price of $0.0001 per share.

F2 · kind: The Pre-Funded Warrants include a "cashless" exercise provision, wherein the holder of the Pre-Funded Warrant is entitled to receive a number of shares of Common Stock generally equal to the quotient obtained by dividing the market price minus the exercise price divided by the market price (as further described in the Pre-Funded Warrant). The Pre-Funded Warrants became exercisable on August 28, 2026, following the receipt of stockholder approval for the issuance of the underlying Common Stock, and, on such date, Corvus exercised all of its Pre-Funded Warrants via cashless exercise and received 5,436,540 shares of Common Stock.

F6 · kind: Corvus exercised the Pre-Funded Warrants on a cashless basis, which resulted in the Issuer withholding 290 shares of Common Stock issuable upon the exercise of the Pre-Funded Warrants to pay the exercise price.

F1 · shares: On July 30, 2026, Corvus Capital Limited ("Corvus") entered into that certain securities purchase agreement (the "Agreement") with CDT Equity Inc. (the "Issuer") and certain other investors of Sarborg Limited, a Cayman Islands Company ("Sarborg"), named therein, pursuant to which, on July 30, 2026, Corvus sold to the Issuer an aggregate of 120 shares of Sarborg (such shares the "Sarborg Shares") and the Issuer issued to Corvus as consideration for the Sarborg Shares pre-funded warrants (the "Pre-Funded Warrants") to purchase up to an aggregate of 5,436,830 shares of common stock, par value $0.0001 per share, of the Issuer (the "Common Stock"), at an exercise price of $0.0001 per share.

F2 · shares: The Pre-Funded Warrants include a "cashless" exercise provision, wherein the holder of the Pre-Funded Warrant is entitled to receive a number of shares of Common Stock generally equal to the quotient obtained by dividing the market price minus the exercise price divided by the market price (as further described in the Pre-Funded Warrant). The Pre-Funded Warrants became exercisable on August 28, 2026, following the receipt of stockholder approval for the issuance of the underlying Common Stock, and, on such date, Corvus exercised all of its Pre-Funded Warrants via cashless exercise and received 5,436,540 shares of Common Stock.

F6 · shares: Corvus exercised the Pre-Funded Warrants on a cashless basis, which resulted in the Issuer withholding 290 shares of Common Stock issuable upon the exercise of the Pre-Funded Warrants to pay the exercise price.

F1 · price: On July 30, 2026, Corvus Capital Limited ("Corvus") entered into that certain securities purchase agreement (the "Agreement") with CDT Equity Inc. (the "Issuer") and certain other investors of Sarborg Limited, a Cayman Islands Company ("Sarborg"), named therein, pursuant to which, on July 30, 2026, Corvus sold to the Issuer an aggregate of 120 shares of Sarborg (such shares the "Sarborg Shares") and the Issuer issued to Corvus as consideration for the Sarborg Shares pre-funded warrants (the "Pre-Funded Warrants") to purchase up to an aggregate of 5,436,830 shares of common stock, par value $0.0001 per share, of the Issuer (the "Common Stock"), at an exercise price of $0.0001 per share.

F2 · price: The Pre-Funded Warrants include a "cashless" exercise provision, wherein the holder of the Pre-Funded Warrant is entitled to receive a number of shares of Common Stock generally equal to the quotient obtained by dividing the market price minus the exercise price divided by the market price (as further described in the Pre-Funded Warrant). The Pre-Funded Warrants became exercisable on August 28, 2026, following the receipt of stockholder approval for the issuance of the underlying Common Stock, and, on such date, Corvus exercised all of its Pre-Funded Warrants via cashless exercise and received 5,436,540 shares of Common Stock.

F3 · ownership.nature: These shares of Common Stock and Pre-Funded Warrants are owned of record by Corvus.

F4 · ownership.nature: Corvus is the owner of 99.0% of the equity interests of Manoira Corporation ("Manoira") and, therefore, may also be deemed to beneficially own the shares of Common Stock held of record by Manoira. Dr. Andrew Regan is the sole director of Manoira and the Chief Executive Officer and sole shareholder of Corvus. By virtue of these relationships, Dr. Regan may be deemed to beneficially own the shares of Common Stock and Pre-Funded Warrants held of record by Manoira and Corvus. Each of Corvus and Dr. Regan disclaims any such beneficial ownership, except to the extent of its or his pecuniary interest therein.

SEC source: 0001753926-26-001698 · ownership.xml · nonDerivative · entry 1

Regan Andrew · CIK 0001991325 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · By Corvus Capital Ltd.

Disclosed balance after: 5,693,223

F1 · shares: On July 30, 2026, Corvus Capital Limited ("Corvus") entered into that certain securities purchase agreement (the "Agreement") with CDT Equity Inc. (the "Issuer") and certain other investors of Sarborg Limited, a Cayman Islands Company ("Sarborg"), named therein, pursuant to which, on July 30, 2026, Corvus sold to the Issuer an aggregate of 120 shares of Sarborg (such shares the "Sarborg Shares") and the Issuer issued to Corvus as consideration for the Sarborg Shares pre-funded warrants (the "Pre-Funded Warrants") to purchase up to an aggregate of 5,436,830 shares of common stock, par value $0.0001 per share, of the Issuer (the "Common Stock"), at an exercise price of $0.0001 per share.

F2 · shares: The Pre-Funded Warrants include a "cashless" exercise provision, wherein the holder of the Pre-Funded Warrant is entitled to receive a number of shares of Common Stock generally equal to the quotient obtained by dividing the market price minus the exercise price divided by the market price (as further described in the Pre-Funded Warrant). The Pre-Funded Warrants became exercisable on August 28, 2026, following the receipt of stockholder approval for the issuance of the underlying Common Stock, and, on such date, Corvus exercised all of its Pre-Funded Warrants via cashless exercise and received 5,436,540 shares of Common Stock.

F1 · price: On July 30, 2026, Corvus Capital Limited ("Corvus") entered into that certain securities purchase agreement (the "Agreement") with CDT Equity Inc. (the "Issuer") and certain other investors of Sarborg Limited, a Cayman Islands Company ("Sarborg"), named therein, pursuant to which, on July 30, 2026, Corvus sold to the Issuer an aggregate of 120 shares of Sarborg (such shares the "Sarborg Shares") and the Issuer issued to Corvus as consideration for the Sarborg Shares pre-funded warrants (the "Pre-Funded Warrants") to purchase up to an aggregate of 5,436,830 shares of common stock, par value $0.0001 per share, of the Issuer (the "Common Stock"), at an exercise price of $0.0001 per share.

F2 · price: The Pre-Funded Warrants include a "cashless" exercise provision, wherein the holder of the Pre-Funded Warrant is entitled to receive a number of shares of Common Stock generally equal to the quotient obtained by dividing the market price minus the exercise price divided by the market price (as further described in the Pre-Funded Warrant). The Pre-Funded Warrants became exercisable on August 28, 2026, following the receipt of stockholder approval for the issuance of the underlying Common Stock, and, on such date, Corvus exercised all of its Pre-Funded Warrants via cashless exercise and received 5,436,540 shares of Common Stock.

F3 · ownership.nature: These shares of Common Stock and Pre-Funded Warrants are owned of record by Corvus.

F4 · ownership.nature: Corvus is the owner of 99.0% of the equity interests of Manoira Corporation ("Manoira") and, therefore, may also be deemed to beneficially own the shares of Common Stock held of record by Manoira. Dr. Andrew Regan is the sole director of Manoira and the Chief Executive Officer and sole shareholder of Corvus. By virtue of these relationships, Dr. Regan may be deemed to beneficially own the shares of Common Stock and Pre-Funded Warrants held of record by Manoira and Corvus. Each of Corvus and Dr. Regan disclaims any such beneficial ownership, except to the extent of its or his pecuniary interest therein.

SEC source: 0001753926-26-001698 · ownership.xml · derivative · entry 5

Regan Andrew · CIK 0001991325 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · By Corvus Capital Ltd.

Disclosed balance after: 5,436,830

Underlying: Common Stock · 5,436,830 shares

Expires not disclosed

F1 · kind: On July 30, 2026, Corvus Capital Limited ("Corvus") entered into that certain securities purchase agreement (the "Agreement") with CDT Equity Inc. (the "Issuer") and certain other investors of Sarborg Limited, a Cayman Islands Company ("Sarborg"), named therein, pursuant to which, on July 30, 2026, Corvus sold to the Issuer an aggregate of 120 shares of Sarborg (such shares the "Sarborg Shares") and the Issuer issued to Corvus as consideration for the Sarborg Shares pre-funded warrants (the "Pre-Funded Warrants") to purchase up to an aggregate of 5,436,830 shares of common stock, par value $0.0001 per share, of the Issuer (the "Common Stock"), at an exercise price of $0.0001 per share.

F2 · kind: The Pre-Funded Warrants include a "cashless" exercise provision, wherein the holder of the Pre-Funded Warrant is entitled to receive a number of shares of Common Stock generally equal to the quotient obtained by dividing the market price minus the exercise price divided by the market price (as further described in the Pre-Funded Warrant). The Pre-Funded Warrants became exercisable on August 28, 2026, following the receipt of stockholder approval for the issuance of the underlying Common Stock, and, on such date, Corvus exercised all of its Pre-Funded Warrants via cashless exercise and received 5,436,540 shares of Common Stock.

F1 · shares: On July 30, 2026, Corvus Capital Limited ("Corvus") entered into that certain securities purchase agreement (the "Agreement") with CDT Equity Inc. (the "Issuer") and certain other investors of Sarborg Limited, a Cayman Islands Company ("Sarborg"), named therein, pursuant to which, on July 30, 2026, Corvus sold to the Issuer an aggregate of 120 shares of Sarborg (such shares the "Sarborg Shares") and the Issuer issued to Corvus as consideration for the Sarborg Shares pre-funded warrants (the "Pre-Funded Warrants") to purchase up to an aggregate of 5,436,830 shares of common stock, par value $0.0001 per share, of the Issuer (the "Common Stock"), at an exercise price of $0.0001 per share.

F2 · shares: The Pre-Funded Warrants include a "cashless" exercise provision, wherein the holder of the Pre-Funded Warrant is entitled to receive a number of shares of Common Stock generally equal to the quotient obtained by dividing the market price minus the exercise price divided by the market price (as further described in the Pre-Funded Warrant). The Pre-Funded Warrants became exercisable on August 28, 2026, following the receipt of stockholder approval for the issuance of the underlying Common Stock, and, on such date, Corvus exercised all of its Pre-Funded Warrants via cashless exercise and received 5,436,540 shares of Common Stock.

F3 · shares: These shares of Common Stock and Pre-Funded Warrants are owned of record by Corvus.

F1 · derivative.exercise_date: On July 30, 2026, Corvus Capital Limited ("Corvus") entered into that certain securities purchase agreement (the "Agreement") with CDT Equity Inc. (the "Issuer") and certain other investors of Sarborg Limited, a Cayman Islands Company ("Sarborg"), named therein, pursuant to which, on July 30, 2026, Corvus sold to the Issuer an aggregate of 120 shares of Sarborg (such shares the "Sarborg Shares") and the Issuer issued to Corvus as consideration for the Sarborg Shares pre-funded warrants (the "Pre-Funded Warrants") to purchase up to an aggregate of 5,436,830 shares of common stock, par value $0.0001 per share, of the Issuer (the "Common Stock"), at an exercise price of $0.0001 per share.

F2 · derivative.exercise_date: The Pre-Funded Warrants include a "cashless" exercise provision, wherein the holder of the Pre-Funded Warrant is entitled to receive a number of shares of Common Stock generally equal to the quotient obtained by dividing the market price minus the exercise price divided by the market price (as further described in the Pre-Funded Warrant). The Pre-Funded Warrants became exercisable on August 28, 2026, following the receipt of stockholder approval for the issuance of the underlying Common Stock, and, on such date, Corvus exercised all of its Pre-Funded Warrants via cashless exercise and received 5,436,540 shares of Common Stock.

F7 · derivative.expiration_date: The Pre-Funded Warrants have been exercised in full.

F1 · derivative.underlying_shares: On July 30, 2026, Corvus Capital Limited ("Corvus") entered into that certain securities purchase agreement (the "Agreement") with CDT Equity Inc. (the "Issuer") and certain other investors of Sarborg Limited, a Cayman Islands Company ("Sarborg"), named therein, pursuant to which, on July 30, 2026, Corvus sold to the Issuer an aggregate of 120 shares of Sarborg (such shares the "Sarborg Shares") and the Issuer issued to Corvus as consideration for the Sarborg Shares pre-funded warrants (the "Pre-Funded Warrants") to purchase up to an aggregate of 5,436,830 shares of common stock, par value $0.0001 per share, of the Issuer (the "Common Stock"), at an exercise price of $0.0001 per share.

F2 · derivative.underlying_shares: The Pre-Funded Warrants include a "cashless" exercise provision, wherein the holder of the Pre-Funded Warrant is entitled to receive a number of shares of Common Stock generally equal to the quotient obtained by dividing the market price minus the exercise price divided by the market price (as further described in the Pre-Funded Warrant). The Pre-Funded Warrants became exercisable on August 28, 2026, following the receipt of stockholder approval for the issuance of the underlying Common Stock, and, on such date, Corvus exercised all of its Pre-Funded Warrants via cashless exercise and received 5,436,540 shares of Common Stock.

F3 · derivative.underlying_shares: These shares of Common Stock and Pre-Funded Warrants are owned of record by Corvus.

F1 · balance_after: On July 30, 2026, Corvus Capital Limited ("Corvus") entered into that certain securities purchase agreement (the "Agreement") with CDT Equity Inc. (the "Issuer") and certain other investors of Sarborg Limited, a Cayman Islands Company ("Sarborg"), named therein, pursuant to which, on July 30, 2026, Corvus sold to the Issuer an aggregate of 120 shares of Sarborg (such shares the "Sarborg Shares") and the Issuer issued to Corvus as consideration for the Sarborg Shares pre-funded warrants (the "Pre-Funded Warrants") to purchase up to an aggregate of 5,436,830 shares of common stock, par value $0.0001 per share, of the Issuer (the "Common Stock"), at an exercise price of $0.0001 per share.

F2 · balance_after: The Pre-Funded Warrants include a "cashless" exercise provision, wherein the holder of the Pre-Funded Warrant is entitled to receive a number of shares of Common Stock generally equal to the quotient obtained by dividing the market price minus the exercise price divided by the market price (as further described in the Pre-Funded Warrant). The Pre-Funded Warrants became exercisable on August 28, 2026, following the receipt of stockholder approval for the issuance of the underlying Common Stock, and, on such date, Corvus exercised all of its Pre-Funded Warrants via cashless exercise and received 5,436,540 shares of Common Stock.

F3 · balance_after: These shares of Common Stock and Pre-Funded Warrants are owned of record by Corvus.

F4 · ownership.nature: Corvus is the owner of 99.0% of the equity interests of Manoira Corporation ("Manoira") and, therefore, may also be deemed to beneficially own the shares of Common Stock held of record by Manoira. Dr. Andrew Regan is the sole director of Manoira and the Chief Executive Officer and sole shareholder of Corvus. By virtue of these relationships, Dr. Regan may be deemed to beneficially own the shares of Common Stock and Pre-Funded Warrants held of record by Manoira and Corvus. Each of Corvus and Dr. Regan disclaims any such beneficial ownership, except to the extent of its or his pecuniary interest therein.

SEC source: 0001753926-26-001040 · ownership.xml · nonDerivative · entry 4

Taylor Mark Andrew · CIK 0002119432 · 10% owner

Prospect Capital Securities Ltd · CIK 0002120744 · 10% owner

Prospect Finance Ltd · CIK 0002120961 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By Prospect Finance Limited

Disclosed balance after: 0

F1 · shares: Number of shares of common stock, par value $0.0001 per share ("Common Stock"), of CDT Equity Inc. (the "Issuer") reported gives effect to the 1-for-25 reverse split of the Common Stock effected by the Company as of the opening of market on March 26, 2026.

F4 · price: On June 18, 2026, Prospect Finance sold 5,000 shares of Common Stock in the open market at a sales price per share of $0.751 and 593,289 shares of Common Stock in the open market at prices ranging from $1.25 to $1.67 per share, inclusive.

F5 · price: The reporting persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of such shares of Common Stock sold at each separate price within such range.

F3 · ownership.nature: Mark Taylor is the sole director and sole shareholder of each of Prospect Capital and Prospect Finance Limited, a New Zealand company ("Prospect Finance"). By virtue of these relationships, Mr. Taylor may be deemed to beneficially own the securities held of record by each of Prospect Capital and Prospect Finance. Mr. Taylor disclaims any such beneficial ownership except to the extent of his pecuniary interest therein.

SEC source: 0001753926-26-001040 · ownership.xml · nonDerivative · entry 3

Taylor Mark Andrew · CIK 0002119432 · 10% owner

Prospect Capital Securities Ltd · CIK 0002120744 · 10% owner

Prospect Finance Ltd · CIK 0002120961 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By Prospect Finance Limited

Disclosed balance after: 593,289

F1 · shares: Number of shares of common stock, par value $0.0001 per share ("Common Stock"), of CDT Equity Inc. (the "Issuer") reported gives effect to the 1-for-25 reverse split of the Common Stock effected by the Company as of the opening of market on March 26, 2026.

F4 · price: On June 18, 2026, Prospect Finance sold 5,000 shares of Common Stock in the open market at a sales price per share of $0.751 and 593,289 shares of Common Stock in the open market at prices ranging from $1.25 to $1.67 per share, inclusive.

F3 · ownership.nature: Mark Taylor is the sole director and sole shareholder of each of Prospect Capital and Prospect Finance Limited, a New Zealand company ("Prospect Finance"). By virtue of these relationships, Mr. Taylor may be deemed to beneficially own the securities held of record by each of Prospect Capital and Prospect Finance. Mr. Taylor disclaims any such beneficial ownership except to the extent of his pecuniary interest therein.

SEC source: 0001753926-26-001040 · ownership.xml · nonDerivative · entry 2

Taylor Mark Andrew · CIK 0002119432 · 10% owner

Prospect Capital Securities Ltd · CIK 0002120744 · 10% owner

Prospect Finance Ltd · CIK 0002120961 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By Prospect Capital Securities Limited

Disclosed balance after: 0

F1 · shares: Number of shares of common stock, par value $0.0001 per share ("Common Stock"), of CDT Equity Inc. (the "Issuer") reported gives effect to the 1-for-25 reverse split of the Common Stock effected by the Company as of the opening of market on March 26, 2026.

F2 · price: On June 18, 2026, Prospect Capital Securities Limited, a New Zealand company ("Prospect Capital") sold 5,000 shares of Common Stock in the open market at a sales price per share of $0.7052 and 1,464,711 shares of Common Stock in the open market at a sales price per share of $1.44.

F3 · ownership.nature: Mark Taylor is the sole director and sole shareholder of each of Prospect Capital and Prospect Finance Limited, a New Zealand company ("Prospect Finance"). By virtue of these relationships, Mr. Taylor may be deemed to beneficially own the securities held of record by each of Prospect Capital and Prospect Finance. Mr. Taylor disclaims any such beneficial ownership except to the extent of his pecuniary interest therein.

SEC source: 0001753926-26-001040 · ownership.xml · nonDerivative · entry 1

Taylor Mark Andrew · CIK 0002119432 · 10% owner

Prospect Capital Securities Ltd · CIK 0002120744 · 10% owner

Prospect Finance Ltd · CIK 0002120961 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By Prospect Capital Securities Limited

Disclosed balance after: 1,464,711

F1 · shares: Number of shares of common stock, par value $0.0001 per share ("Common Stock"), of CDT Equity Inc. (the "Issuer") reported gives effect to the 1-for-25 reverse split of the Common Stock effected by the Company as of the opening of market on March 26, 2026.

F2 · price: On June 18, 2026, Prospect Capital Securities Limited, a New Zealand company ("Prospect Capital") sold 5,000 shares of Common Stock in the open market at a sales price per share of $0.7052 and 1,464,711 shares of Common Stock in the open market at a sales price per share of $1.44.

F3 · ownership.nature: Mark Taylor is the sole director and sole shareholder of each of Prospect Capital and Prospect Finance Limited, a New Zealand company ("Prospect Finance"). By virtue of these relationships, Mr. Taylor may be deemed to beneficially own the securities held of record by each of Prospect Capital and Prospect Finance. Mr. Taylor disclaims any such beneficial ownership except to the extent of his pecuniary interest therein.

SEC source: 0001753926-26-000867 · ownership.xml · nonDerivative · entry 2

Regan Andrew · CIK 0001991325 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · By Corvus Capital Ltd.

Disclosed balance after: 256,393

F4 · shares: On May 13, 2026, Corvus purchased a total of 100,000 shares of Common Stock in the open market at a price per share of $1.90 for total cash consideration of $190,000.

F4 · price: On May 13, 2026, Corvus purchased a total of 100,000 shares of Common Stock in the open market at a price per share of $1.90 for total cash consideration of $190,000.

F3 · ownership.nature: These shares of Common Stock are owned of record by Corvus.

F6 · ownership.nature: Corvus is the owner of 99.0% of the equity interests of Manoira and, therefore, may also be deemed to beneficially own the shares of Common Stock held of record by Manoira. Dr. Regan is the sole director of Manoira and the Chief Executive Officer and sole shareholder of Corvus. By virtue of these relationships, Dr. Regan may be deemed to beneficially own the shares of Common Stock held of record by Manoira and Corvus. Each of Corvus and Dr. Regan disclaims any such beneficial ownership, except to the extent of its or his pecuniary interest therein.

SEC source: 0001753926-26-000867 · ownership.xml · derivative · entry 5

Regan Andrew · CIK 0001991325 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · By Corvus Capital Ltd.

Disclosed balance after: 0

Underlying: Common Stock · 147,401 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: On March 26, 2026, CDT Equity Inc. (the "Company") effected a 1-for-25 reverse stock split (the "Reverse Stock Split") of the Company's outstanding shares of common stock, par value $0.0001 per share (the "Common Stock"). The number of shares of Common Stock and prices reported on this Form 4 have been adjusted to reflect the Reverse Stock Split. Corvus ceased to be a 10% holder as of February 19, 2026.

F2 · shares: On March 24, 2026, Corvus Capital Limited ("Corvus") exercised all its pre-funded warrants (the "Pre-Funded Warrants") via cashless exercise for 147,401 shares of Common Stock.

F7 · derivative.expiration_date: The Pre-Funded Warrants have been exercised in full.

F1 · derivative.underlying_shares: On March 26, 2026, CDT Equity Inc. (the "Company") effected a 1-for-25 reverse stock split (the "Reverse Stock Split") of the Company's outstanding shares of common stock, par value $0.0001 per share (the "Common Stock"). The number of shares of Common Stock and prices reported on this Form 4 have been adjusted to reflect the Reverse Stock Split. Corvus ceased to be a 10% holder as of February 19, 2026.

F2 · derivative.underlying_shares: On March 24, 2026, Corvus Capital Limited ("Corvus") exercised all its pre-funded warrants (the "Pre-Funded Warrants") via cashless exercise for 147,401 shares of Common Stock.

F1 · balance_after: On March 26, 2026, CDT Equity Inc. (the "Company") effected a 1-for-25 reverse stock split (the "Reverse Stock Split") of the Company's outstanding shares of common stock, par value $0.0001 per share (the "Common Stock"). The number of shares of Common Stock and prices reported on this Form 4 have been adjusted to reflect the Reverse Stock Split. Corvus ceased to be a 10% holder as of February 19, 2026.

F2 · balance_after: On March 24, 2026, Corvus Capital Limited ("Corvus") exercised all its pre-funded warrants (the "Pre-Funded Warrants") via cashless exercise for 147,401 shares of Common Stock.

F3 · ownership.nature: These shares of Common Stock are owned of record by Corvus.

F6 · ownership.nature: Corvus is the owner of 99.0% of the equity interests of Manoira and, therefore, may also be deemed to beneficially own the shares of Common Stock held of record by Manoira. Dr. Regan is the sole director of Manoira and the Chief Executive Officer and sole shareholder of Corvus. By virtue of these relationships, Dr. Regan may be deemed to beneficially own the shares of Common Stock held of record by Manoira and Corvus. Each of Corvus and Dr. Regan disclaims any such beneficial ownership, except to the extent of its or his pecuniary interest therein.

SEC source: 0001753926-26-000867 · ownership.xml · nonDerivative · entry 1

Regan Andrew · CIK 0001991325 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · By Corvus Capital Ltd.

Disclosed balance after: 156,393

F1 · shares: On March 26, 2026, CDT Equity Inc. (the "Company") effected a 1-for-25 reverse stock split (the "Reverse Stock Split") of the Company's outstanding shares of common stock, par value $0.0001 per share (the "Common Stock"). The number of shares of Common Stock and prices reported on this Form 4 have been adjusted to reflect the Reverse Stock Split. Corvus ceased to be a 10% holder as of February 19, 2026.

F2 · shares: On March 24, 2026, Corvus Capital Limited ("Corvus") exercised all its pre-funded warrants (the "Pre-Funded Warrants") via cashless exercise for 147,401 shares of Common Stock.

F2 · price: On March 24, 2026, Corvus Capital Limited ("Corvus") exercised all its pre-funded warrants (the "Pre-Funded Warrants") via cashless exercise for 147,401 shares of Common Stock.

F3 · ownership.nature: These shares of Common Stock are owned of record by Corvus.

F6 · ownership.nature: Corvus is the owner of 99.0% of the equity interests of Manoira and, therefore, may also be deemed to beneficially own the shares of Common Stock held of record by Manoira. Dr. Regan is the sole director of Manoira and the Chief Executive Officer and sole shareholder of Corvus. By virtue of these relationships, Dr. Regan may be deemed to beneficially own the shares of Common Stock held of record by Manoira and Corvus. Each of Corvus and Dr. Regan disclaims any such beneficial ownership, except to the extent of its or his pecuniary interest therein.

SEC source: 0001753926-26-000583 · ownership.xml · derivative · entry 4

Taylor Mark Andrew · CIK 0002119432 · 10% owner

Prospect Capital Securities Ltd · CIK 0002120744 · 10% owner

Prospect Finance Ltd · CIK 0002120961 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By Prospect Capital Securities Limited and Prospect Finance Limited

Disclosed balance after: 0

Underlying: Common Stock · 51,161,318 shares

Expires not disclosed

F3 · derivative.exercise_price: On March 17, 2026, following the certification of the results of the Issuer's special meeting of stockholders wherein the stockholders approved the issuance of Common Stock upon the exercise of the Pre-Funded Warrants, the Pre-Funded Warrants became exercisable and Prospect Capital and Prospect Finance each exercised all of their Pre-Funded Warrants pursuant to the "cashless" exercise provision thereof and received 36,544,028 and 14,876,330 shares of Common Stock, respectively. The Pre-Funded Warrants have no expiration date and are exercisable until exercised in full.

F3 · date: On March 17, 2026, following the certification of the results of the Issuer's special meeting of stockholders wherein the stockholders approved the issuance of Common Stock upon the exercise of the Pre-Funded Warrants, the Pre-Funded Warrants became exercisable and Prospect Capital and Prospect Finance each exercised all of their Pre-Funded Warrants pursuant to the "cashless" exercise provision thereof and received 36,544,028 and 14,876,330 shares of Common Stock, respectively. The Pre-Funded Warrants have no expiration date and are exercisable until exercised in full.

F1 · shares: On February 19, 2026, Prospect Finance Limited, a New Zealand company ("Prospect Finance"), transferred (i) 46,902 shares of common stock, par value $0.0001 per share (the "Common Stock"), of CDT Equity Inc. (the "Issuer"), and (ii) pre-funded warrants (the "Pre-Funded Warrants") to purchase 9,968,931 shares of Common Stock, to a third party, each for no consideration.

F3 · shares: On March 17, 2026, following the certification of the results of the Issuer's special meeting of stockholders wherein the stockholders approved the issuance of Common Stock upon the exercise of the Pre-Funded Warrants, the Pre-Funded Warrants became exercisable and Prospect Capital and Prospect Finance each exercised all of their Pre-Funded Warrants pursuant to the "cashless" exercise provision thereof and received 36,544,028 and 14,876,330 shares of Common Stock, respectively. The Pre-Funded Warrants have no expiration date and are exercisable until exercised in full.

F3 · price: On March 17, 2026, following the certification of the results of the Issuer's special meeting of stockholders wherein the stockholders approved the issuance of Common Stock upon the exercise of the Pre-Funded Warrants, the Pre-Funded Warrants became exercisable and Prospect Capital and Prospect Finance each exercised all of their Pre-Funded Warrants pursuant to the "cashless" exercise provision thereof and received 36,544,028 and 14,876,330 shares of Common Stock, respectively. The Pre-Funded Warrants have no expiration date and are exercisable until exercised in full.

F1 · derivative.exercise_date: On February 19, 2026, Prospect Finance Limited, a New Zealand company ("Prospect Finance"), transferred (i) 46,902 shares of common stock, par value $0.0001 per share (the "Common Stock"), of CDT Equity Inc. (the "Issuer"), and (ii) pre-funded warrants (the "Pre-Funded Warrants") to purchase 9,968,931 shares of Common Stock, to a third party, each for no consideration.

F3 · derivative.expiration_date: On March 17, 2026, following the certification of the results of the Issuer's special meeting of stockholders wherein the stockholders approved the issuance of Common Stock upon the exercise of the Pre-Funded Warrants, the Pre-Funded Warrants became exercisable and Prospect Capital and Prospect Finance each exercised all of their Pre-Funded Warrants pursuant to the "cashless" exercise provision thereof and received 36,544,028 and 14,876,330 shares of Common Stock, respectively. The Pre-Funded Warrants have no expiration date and are exercisable until exercised in full.

F2 · ownership.nature: Mark Taylor is the sole director and sole shareholder of each of Prospect Capital Securities Limited, a New Zealand company ("Prospect Capital"), and Prospect Finance. By virtue of these relationships, Mr. Taylor may be deemed to beneficially own the securities held of record by each of Prospect Capital and Prospect Finance. Mr. Taylor disclaims any such beneficial ownership except to the extent of his pecuniary interest therein.

SEC source: 0001753926-26-000583 · ownership.xml · nonDerivative · entry 2

Taylor Mark Andrew · CIK 0002119432 · 10% owner

Prospect Capital Securities Ltd · CIK 0002120744 · 10% owner

Prospect Finance Ltd · CIK 0002120961 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By Prospect Capital Securities Limited and Prospect Finance Limited

Disclosed balance after: 51,700,014

F3 · date: On March 17, 2026, following the certification of the results of the Issuer's special meeting of stockholders wherein the stockholders approved the issuance of Common Stock upon the exercise of the Pre-Funded Warrants, the Pre-Funded Warrants became exercisable and Prospect Capital and Prospect Finance each exercised all of their Pre-Funded Warrants pursuant to the "cashless" exercise provision thereof and received 36,544,028 and 14,876,330 shares of Common Stock, respectively. The Pre-Funded Warrants have no expiration date and are exercisable until exercised in full.

F2 · shares: Mark Taylor is the sole director and sole shareholder of each of Prospect Capital Securities Limited, a New Zealand company ("Prospect Capital"), and Prospect Finance. By virtue of these relationships, Mr. Taylor may be deemed to beneficially own the securities held of record by each of Prospect Capital and Prospect Finance. Mr. Taylor disclaims any such beneficial ownership except to the extent of his pecuniary interest therein.

F3 · shares: On March 17, 2026, following the certification of the results of the Issuer's special meeting of stockholders wherein the stockholders approved the issuance of Common Stock upon the exercise of the Pre-Funded Warrants, the Pre-Funded Warrants became exercisable and Prospect Capital and Prospect Finance each exercised all of their Pre-Funded Warrants pursuant to the "cashless" exercise provision thereof and received 36,544,028 and 14,876,330 shares of Common Stock, respectively. The Pre-Funded Warrants have no expiration date and are exercisable until exercised in full.

F3 · price: On March 17, 2026, following the certification of the results of the Issuer's special meeting of stockholders wherein the stockholders approved the issuance of Common Stock upon the exercise of the Pre-Funded Warrants, the Pre-Funded Warrants became exercisable and Prospect Capital and Prospect Finance each exercised all of their Pre-Funded Warrants pursuant to the "cashless" exercise provision thereof and received 36,544,028 and 14,876,330 shares of Common Stock, respectively. The Pre-Funded Warrants have no expiration date and are exercisable until exercised in full.

F2 · balance_after: Mark Taylor is the sole director and sole shareholder of each of Prospect Capital Securities Limited, a New Zealand company ("Prospect Capital"), and Prospect Finance. By virtue of these relationships, Mr. Taylor may be deemed to beneficially own the securities held of record by each of Prospect Capital and Prospect Finance. Mr. Taylor disclaims any such beneficial ownership except to the extent of his pecuniary interest therein.

F2 · ownership.nature: Mark Taylor is the sole director and sole shareholder of each of Prospect Capital Securities Limited, a New Zealand company ("Prospect Capital"), and Prospect Finance. By virtue of these relationships, Mr. Taylor may be deemed to beneficially own the securities held of record by each of Prospect Capital and Prospect Finance. Mr. Taylor disclaims any such beneficial ownership except to the extent of his pecuniary interest therein.

SEC source: 0001493152-26-007794 · ownership.xml · derivative · entry 2

Farley Chele Chiavacci · CIK 0001908750 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,940,804

Underlying: Common Stock · 1,940,804 shares

Expires not disclosed

F1 · price: On February 19, 2026, CDT Equity Inc. (the "Company") entered into a Securities Purchase Agreement (the "Purchase Agreement") with the reporting person and other stockholders (the "Investors") of Sarborg Limited, a Cayman Islands Company ("Sarborg"), pursuant to which the reporting person agreed to sell to the Company, and the Company agreed to acquire from the reporting person, 18 shares of Sarborg having an aggregate value of approximately $2,029,411 in exchange for (i) 10,553 shares of the Company's Common Stock, and (ii) pre-funded warrants (the "Pre-Funded Warrants") to purchase up to 1,940,804 shares of the Company's Common Stock, reflecting a purchase price of $1.04 per share.

F2 · derivative.exercise_date: The Pre-Funded Warrants may not be exercised until the Company obtains requisite stockholder approval in accordance with Nasdaq Listing Rule 5635.

F3 · derivative.expiration_date: The Pre-Funded Warrants will remain exercisable until all Pre-Funded Warrants are exercised in full.

SEC source: 0001493152-26-007794 · ownership.xml · nonDerivative · entry 1

Farley Chele Chiavacci · CIK 0001908750 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,157

F1 · shares: On February 19, 2026, CDT Equity Inc. (the "Company") entered into a Securities Purchase Agreement (the "Purchase Agreement") with the reporting person and other stockholders (the "Investors") of Sarborg Limited, a Cayman Islands Company ("Sarborg"), pursuant to which the reporting person agreed to sell to the Company, and the Company agreed to acquire from the reporting person, 18 shares of Sarborg having an aggregate value of approximately $2,029,411 in exchange for (i) 10,553 shares of the Company's Common Stock, and (ii) pre-funded warrants (the "Pre-Funded Warrants") to purchase up to 1,940,804 shares of the Company's Common Stock, reflecting a purchase price of $1.04 per share.

SEC source: 0001753926-26-000583 · ownership.xml · derivative · entry 3

Taylor Mark Andrew · CIK 0002119432 · 10% owner

Prospect Capital Securities Ltd · CIK 0002120744 · 10% owner

Prospect Finance Ltd · CIK 0002120961 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By Prospect Finance Limited

Disclosed balance after: 14,609,501

Underlying: Common Stock · 9,968,931 shares

Expires not disclosed

F1 · derivative.exercise_price: On February 19, 2026, Prospect Finance Limited, a New Zealand company ("Prospect Finance"), transferred (i) 46,902 shares of common stock, par value $0.0001 per share (the "Common Stock"), of CDT Equity Inc. (the "Issuer"), and (ii) pre-funded warrants (the "Pre-Funded Warrants") to purchase 9,968,931 shares of Common Stock, to a third party, each for no consideration.

F1 · date: On February 19, 2026, Prospect Finance Limited, a New Zealand company ("Prospect Finance"), transferred (i) 46,902 shares of common stock, par value $0.0001 per share (the "Common Stock"), of CDT Equity Inc. (the "Issuer"), and (ii) pre-funded warrants (the "Pre-Funded Warrants") to purchase 9,968,931 shares of Common Stock, to a third party, each for no consideration.

F1 · shares: On February 19, 2026, Prospect Finance Limited, a New Zealand company ("Prospect Finance"), transferred (i) 46,902 shares of common stock, par value $0.0001 per share (the "Common Stock"), of CDT Equity Inc. (the "Issuer"), and (ii) pre-funded warrants (the "Pre-Funded Warrants") to purchase 9,968,931 shares of Common Stock, to a third party, each for no consideration.

F1 · price: On February 19, 2026, Prospect Finance Limited, a New Zealand company ("Prospect Finance"), transferred (i) 46,902 shares of common stock, par value $0.0001 per share (the "Common Stock"), of CDT Equity Inc. (the "Issuer"), and (ii) pre-funded warrants (the "Pre-Funded Warrants") to purchase 9,968,931 shares of Common Stock, to a third party, each for no consideration.

F3 · derivative.exercise_date: On March 17, 2026, following the certification of the results of the Issuer's special meeting of stockholders wherein the stockholders approved the issuance of Common Stock upon the exercise of the Pre-Funded Warrants, the Pre-Funded Warrants became exercisable and Prospect Capital and Prospect Finance each exercised all of their Pre-Funded Warrants pursuant to the "cashless" exercise provision thereof and received 36,544,028 and 14,876,330 shares of Common Stock, respectively. The Pre-Funded Warrants have no expiration date and are exercisable until exercised in full.

F3 · derivative.expiration_date: On March 17, 2026, following the certification of the results of the Issuer's special meeting of stockholders wherein the stockholders approved the issuance of Common Stock upon the exercise of the Pre-Funded Warrants, the Pre-Funded Warrants became exercisable and Prospect Capital and Prospect Finance each exercised all of their Pre-Funded Warrants pursuant to the "cashless" exercise provision thereof and received 36,544,028 and 14,876,330 shares of Common Stock, respectively. The Pre-Funded Warrants have no expiration date and are exercisable until exercised in full.

F2 · ownership.nature: Mark Taylor is the sole director and sole shareholder of each of Prospect Capital Securities Limited, a New Zealand company ("Prospect Capital"), and Prospect Finance. By virtue of these relationships, Mr. Taylor may be deemed to beneficially own the securities held of record by each of Prospect Capital and Prospect Finance. Mr. Taylor disclaims any such beneficial ownership except to the extent of his pecuniary interest therein.

SEC source: 0001753926-26-000583 · ownership.xml · nonDerivative · entry 1

Taylor Mark Andrew · CIK 0002119432 · 10% owner

Prospect Capital Securities Ltd · CIK 0002120744 · 10% owner

Prospect Finance Ltd · CIK 0002120961 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By Prospect Finance Limited

Disclosed balance after: 279,656

F1 · date: On February 19, 2026, Prospect Finance Limited, a New Zealand company ("Prospect Finance"), transferred (i) 46,902 shares of common stock, par value $0.0001 per share (the "Common Stock"), of CDT Equity Inc. (the "Issuer"), and (ii) pre-funded warrants (the "Pre-Funded Warrants") to purchase 9,968,931 shares of Common Stock, to a third party, each for no consideration.

F1 · shares: On February 19, 2026, Prospect Finance Limited, a New Zealand company ("Prospect Finance"), transferred (i) 46,902 shares of common stock, par value $0.0001 per share (the "Common Stock"), of CDT Equity Inc. (the "Issuer"), and (ii) pre-funded warrants (the "Pre-Funded Warrants") to purchase 9,968,931 shares of Common Stock, to a third party, each for no consideration.

F2 · shares: Mark Taylor is the sole director and sole shareholder of each of Prospect Capital Securities Limited, a New Zealand company ("Prospect Capital"), and Prospect Finance. By virtue of these relationships, Mr. Taylor may be deemed to beneficially own the securities held of record by each of Prospect Capital and Prospect Finance. Mr. Taylor disclaims any such beneficial ownership except to the extent of his pecuniary interest therein.

F1 · price: On February 19, 2026, Prospect Finance Limited, a New Zealand company ("Prospect Finance"), transferred (i) 46,902 shares of common stock, par value $0.0001 per share (the "Common Stock"), of CDT Equity Inc. (the "Issuer"), and (ii) pre-funded warrants (the "Pre-Funded Warrants") to purchase 9,968,931 shares of Common Stock, to a third party, each for no consideration.

F2 · balance_after: Mark Taylor is the sole director and sole shareholder of each of Prospect Capital Securities Limited, a New Zealand company ("Prospect Capital"), and Prospect Finance. By virtue of these relationships, Mr. Taylor may be deemed to beneficially own the securities held of record by each of Prospect Capital and Prospect Finance. Mr. Taylor disclaims any such beneficial ownership except to the extent of his pecuniary interest therein.

F2 · ownership.nature: Mark Taylor is the sole director and sole shareholder of each of Prospect Capital Securities Limited, a New Zealand company ("Prospect Capital"), and Prospect Finance. By virtue of these relationships, Mr. Taylor may be deemed to beneficially own the securities held of record by each of Prospect Capital and Prospect Finance. Mr. Taylor disclaims any such beneficial ownership except to the extent of his pecuniary interest therein.

SEC source: 0001493152-25-028761 · ownership.xml · derivative · entry 5

Regan Andrew · CIK 0001991325 · Director · Chief Executive Officer · 10% owner

Corvus Capital Ltd. · CIK 0001990829 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By Corvus Capital Ltd.

Disclosed balance after: 3,685,815

Underlying: Common Stock · 3,685,815 shares

Expires not disclosed

F1 · shares: On December 8, 2025, CDT Equity Inc. (the "Company") and Corvus Capital Limited ("Corvus") entered into a Sale and Purchase Agreement, pursuant to which the Company issued to Corvus 224,800 shares of common stock, par value $0.0001 per share of the Company, and pre-funded warrants to purchase up to 3,685,815 shares of Common Stock (the "Pre-Funded Warrants"), pursuant to the acquisition of Conduit Pharmaceuticals Limited and its liabilities.

F7 · derivative.expiration_date: Until exercised in full.

F1 · derivative.underlying_shares: On December 8, 2025, CDT Equity Inc. (the "Company") and Corvus Capital Limited ("Corvus") entered into a Sale and Purchase Agreement, pursuant to which the Company issued to Corvus 224,800 shares of common stock, par value $0.0001 per share of the Company, and pre-funded warrants to purchase up to 3,685,815 shares of Common Stock (the "Pre-Funded Warrants"), pursuant to the acquisition of Conduit Pharmaceuticals Limited and its liabilities.

F1 · balance_after: On December 8, 2025, CDT Equity Inc. (the "Company") and Corvus Capital Limited ("Corvus") entered into a Sale and Purchase Agreement, pursuant to which the Company issued to Corvus 224,800 shares of common stock, par value $0.0001 per share of the Company, and pre-funded warrants to purchase up to 3,685,815 shares of Common Stock (the "Pre-Funded Warrants"), pursuant to the acquisition of Conduit Pharmaceuticals Limited and its liabilities.

F3 · ownership.nature: These shares of Common Stock are owned of record by Corvus.

F6 · ownership.nature: Corvus is the owner of 99.0% of the equity interests of Manoira and Algo is a wholly owned subsidiary of Corvus, and, therefore, may also be deemed to beneficially own the shares of Common Stock held of record by Manoira and Algo. Dr. Regan is the sole director of Manoira and the Chief Executive Officer and sole shareholder of Corvus. By virtue of these relationships, Dr. Regan may be deemed to beneficially own the shares of Common Stock held of record by Manoira, Algo and Corvus. Each of Corvus and Dr. Regan disclaims any such beneficial ownership, including with respect to the Pre-Funded Warrant Shares, except to the extent of its or his pecuniary interest therein.

SEC source: 0001493152-25-028761 · ownership.xml · nonDerivative · entry 1

Regan Andrew · CIK 0001991325 · Director · Chief Executive Officer · 10% owner

Corvus Capital Ltd. · CIK 0001990829 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By Corvus Capital Ltd.

Disclosed balance after: 227,304

F1 · shares: On December 8, 2025, CDT Equity Inc. (the "Company") and Corvus Capital Limited ("Corvus") entered into a Sale and Purchase Agreement, pursuant to which the Company issued to Corvus 224,800 shares of common stock, par value $0.0001 per share of the Company, and pre-funded warrants to purchase up to 3,685,815 shares of Common Stock (the "Pre-Funded Warrants"), pursuant to the acquisition of Conduit Pharmaceuticals Limited and its liabilities.

F2 · price: Based on the closing price per share of Common Stock on December 7, 2025.

F3 · ownership.nature: These shares of Common Stock are owned of record by Corvus.

F6 · ownership.nature: Corvus is the owner of 99.0% of the equity interests of Manoira and Algo is a wholly owned subsidiary of Corvus, and, therefore, may also be deemed to beneficially own the shares of Common Stock held of record by Manoira and Algo. Dr. Regan is the sole director of Manoira and the Chief Executive Officer and sole shareholder of Corvus. By virtue of these relationships, Dr. Regan may be deemed to beneficially own the shares of Common Stock held of record by Manoira, Algo and Corvus. Each of Corvus and Dr. Regan disclaims any such beneficial ownership, including with respect to the Pre-Funded Warrant Shares, except to the extent of its or his pecuniary interest therein.

SEC source: 0001493152-25-014283 · ownership.xml · nonDerivative · entry 1

Bligh James · CIK 0001990748 · Director · CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 480,024

F1 · shares: Represents shares of restricted stock granted on September 19, 2025 under the Issuer's Amended and Restated 2023 Stock Incentive Plan having a value equal to approximately $329,424 based on the closing price per share of the Issuer's common stock on September 18, 2025. The shares of restricted stock vest immediately upon grant.

SEC source: 0001493152-25-014477 · ownership.xml · nonDerivative · entry 1

Regan Andrew · CIK 0001991325 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,120,044

F1 · shares: On September 19, 2025, CDT Equity Inc. (formerly known as Conduit Pharmaceuticals Inc. (the "Issuer")) granted Dr. Andrew Regan ("Dr. Regan") 1,120,000 shares of common stock, par value $0.0001 ("Common Stock"), of the Issuer pursuant to the Issuer's Amended and Restated 2023 Stock Incentive Plan as compensation for his services as a director and an officer of the Issuer.

F2 · price: Based on the closing price per share of Common Stock on September 18, 2025.

SEC source: 0001641172-25-025539 · ownership.xml · nonDerivative · entry 1

Lewis-Hall Freda C · CIK 0001437909 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38,466

F1 · shares: Represents restricted stock units ("RSUs") received on August 12, 2025, in exchange for past services, having a value equal to approximately $60,900 based on the closing price per share of the Issuer's common stock on August 12, 2025. The RSUs vest immediately upon grant.

SEC source: 0001641172-25-025542 · ownership.xml · nonDerivative · entry 1

Fry Simon Jeremy · CIK 0002046305 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 36,956

F1 · shares: Represents restricted stock units ("RSUs") received on August 12, 2025, in exchange for past services, having a value equal to approximately $60,900 based on the closing price per share of the Issuer's common stock on August 12, 2025. The RSUs vest immediately upon grant.

SEC source: 0001641172-25-025538 · ownership.xml · nonDerivative · entry 1

Farley Chele Chiavacci · CIK 0001908750 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,369

F1 · shares: Represents restricted stock units ("RSUs") received on August 12, 2025, in exchange for past services, having a value equal to approximately $60,900 based on the closing price per share of the Issuer's common stock on August 12, 2025. The RSUs vest immediately upon grant.

SEC source: 0001641172-25-025539 · ownership.xml · derivative · entry 4

Lewis-Hall Freda C · CIK 0001437909 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Common Stock · 15,000 shares

Expires 2035-08-05

F4 · security: Represents options to purchase common stock, granted under the Issuer's 2023 Stock Incentive Plan, which were granted at the conclusion of the Issuer's 2025 annual meeting of stockholders.

F5 · derivative.exercise_date: The options vest immediately upon grant.

SEC source: 0001641172-25-025542 · ownership.xml · derivative · entry 2

Fry Simon Jeremy · CIK 0002046305 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Common Stock · 15,000 shares

Expires 2035-08-05

F2 · security: Represents options to purchase common stock, granted under the Issuer's 2023 Stock Incentive Plan, which were granted at the conclusion of the Issuer's 2025 annual meeting of stockholders.

F3 · derivative.exercise_date: The options vest immediately upon grant.

SEC source: 0001641172-25-025538 · ownership.xml · derivative · entry 2

Farley Chele Chiavacci · CIK 0001908750 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Common Stock · 15,000 shares

Expires 2035-08-05

F2 · security: Represents options to purchase common stock, granted under the Issuer's 2023 Stock Incentive Plan, which were granted at the conclusion of the Issuer's 2025 annual meeting of stockholders.

F3 · derivative.exercise_date: The options vest immediately upon grant.

SEC source: 0001641172-25-014963 · ownership.xml · nonDerivative · entry 1

Regan Andrew · CIK 0001991325 · Director · Chief Executive Officer · 10% owner

Corvus Capital Ltd. · CIK 0001990829 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 154,799

F1 · price: Based on the closing price per share of the Issuer's common stock, par value $0.0001 ("Common Stock"), on June 3, 2025.

F2 · ownership.nature: These shares of Common Stock are owned of record by Manoira Corporation ("Manoira"). On June 3, 2025, the Issuer issued 154,799 shares of Common Stock to Manoira pursuant to that certain joint development agreement (the "Joint Development Agreement") by and between the Issuer and Manoira, representing an up-front consideration of $500,000.

SEC source: 0001641172-25-005221 · ownership.xml · nonDerivative · entry 1

Charles Faith L. · CIK 0001853985 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 165,238

SEC source: 0001641172-25-002240 · ownership.xml · nonDerivative · entry 1

Lewis-Hall Freda C · CIK 0001437909 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 51,991

F1 · shares: Represents shares issued pursuant to the 2023 Stock Incentive Plan, in lieu of $42,375 accrued in cash retainers under the Issuer's Non-Employee Director Compensation Program.

SEC source: 0001641172-25-002236 · ownership.xml · nonDerivative · entry 1

Farley Chele Chiavacci · CIK 0001908750 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,537

F1 · shares: Represents shares issued pursuant to the 2023 Stock Incentive Plan, in lieu of $28,500 accrued in cash retainers under the Issuer's Non-Employee Director Compensation Program.

SEC source: 0001641172-25-002238 · ownership.xml · nonDerivative · entry 1

Fry Simon Jeremy · CIK 0002046305 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,354

F1 · shares: Represents shares issued pursuant to the 2023 Stock Incentive Plan, in lieu of $26,125 accrued in cash retainers under the Issuer's Non-Employee Director Compensation Program.

SEC source: 0001641172-25-002234 · ownership.xml · nonDerivative · entry 1

Charles Faith L. · CIK 0001853985 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,044

F1 · shares: Represents shares issued pursuant to the 2023 Stock Incentive Plan, in lieu of $41,500 accrued in cash retainers under the Issuer's Non-Employee Director Compensation Program.

SEC source: 0001493152-24-051098 · ownership.xml · derivative · entry 1

Farley Chele Chiavacci · CIK 0001908750 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 420,000

Underlying: Common Stock · 420,000 shares

Expires 2034-12-18

F1 · security: Represents options to purchase common stock, granted under the Issuer's 2023 Stock Incentive Plan, which were granted at the conclusion of the Issuer's 2024 annual meeting of stockholders.

F2 · derivative.exercise_date: The options will vest on the earlier of (x) the first anniversary of the date of grant, or (y) the date immediately prior to the next annual meeting of the Issuer's stockholders following the date of grant.

SEC source: 0001493152-24-051099 · ownership.xml · derivative · entry 1

Lewis-Hall Freda C · CIK 0001437909 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 420,000

Underlying: Common Stock · 420,000 shares

Expires 2034-12-18

F1 · security: Represents options to purchase common stock, granted under the Issuer's 2023 Stock Incentive Plan, which were granted at the conclusion of the Issuer's 2024 annual meeting of stockholders.

F2 · derivative.exercise_date: The options will vest on the earlier of (x) the first anniversary of the date of grant, or (y) the date immediately prior to the next annual meeting of the Issuer's stockholders following the date of grant.

SEC source: 0001493152-24-051097 · ownership.xml · derivative · entry 1

Charles Faith L. · CIK 0001853985 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 420,000

Underlying: Common Stock · 420,000 shares

Expires 2034-12-18

F1 · security: Represents options to purchase common stock, granted under the Issuer's 2023 Stock Incentive Plan, which were granted at the conclusion of the Issuer's 2024 annual meeting of stockholders.

F2 · derivative.exercise_date: The options will vest on the earlier of (x) the first anniversary of the date of grant, or (y) the date immediately prior to the next annual meeting of the Issuer's stockholders following the date of grant.

SEC source: 0001493152-24-051096 · ownership.xml · derivative · entry 1

Fry Simon Jeremy · CIK 0002046305 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 420,000

Underlying: Common Stock · 420,000 shares

Expires 2034-12-18

F1 · security: Represents options to purchase common stock, granted under the Issuer's 2023 Stock Incentive Plan, which were granted at the conclusion of the Issuer's 2024 annual meeting of stockholders.

F2 · derivative.exercise_date: The options will vest in equal annual installments on the first three anniversaries of the grant date.

SEC source: 0001493152-24-046993 · ownership.xml · nonDerivative · entry 1

Lewis-Hall Freda C · CIK 0001437909 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 437,976

F1 · shares: Represents shares issued in lieu of $40,250 accrued in cash retainers under the Issuer's Non-Employee Director Compensation Program.

SEC source: 0001493152-24-046994 · ownership.xml · derivative · entry 1

Tapolczay David · CIK 0001991789 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 840,000

Underlying: Common Stock · 840,000 shares

Expires 2034-11-18

F1 · security: Represents Options to purchase common stock, granted under the Issuer's 2023 Stock Incentive Plan.

F2 · derivative.exercise_date: The Options vest as follows: (i) 50% on the grant date and (ii) 50% in equal annual installments on the first three anniversaries of the grant date.

SEC source: 0001493152-24-046992 · ownership.xml · nonDerivative · entry 1

Farley Chele Chiavacci · CIK 0001908750 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 351,510

F1 · shares: Represents shares issued in lieu of $27,500 accrued in cash retainers under the Issuer's Non-Employee Director Compensation Program.

SEC source: 0001493152-24-046990 · ownership.xml · derivative · entry 1

Bligh James · CIK 0001990748 · Director · Interim CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,890,000

Underlying: Common Stock · 1,890,000 shares

Expires 2034-11-18

F1 · security: Represents Options to purchase common stock, granted under the Issuer's 2023 Stock Incentive Plan.

F2 · derivative.exercise_date: The Options vest as follows: (i) 50% on the grant date and (ii) 50% in equal annual installments on the first three anniversaries of the grant date.

SEC source: 0001493152-24-046991 · ownership.xml · nonDerivative · entry 2

Charles Faith L. · CIK 0001853985 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 341,594

F2 · shares: Represents shares issued in lieu of $24,500 accrued in cash retainers under the Issuer's Non-Employee Director Compensation Program.

SEC source: 0001493152-24-046991 · ownership.xml · nonDerivative · entry 1

Charles Faith L. · CIK 0001853985 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 75,000

F1 · price: The shares are fully vested and were granted under the Issuer's 2023 Stock Incentive Plan.

SEC source: 0001213900-24-086022 · ownership.xml · nonDerivative · entry 3

Nirland Ltd · CIK 0001994188 · 10% owner

Stockton Ltd · CIK 0001994176 · 10% owner

Rowland Master Trust · CIK 0001994314 · 10% owner

Dovet Ltd · CIK 0001994209 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,092,000

F1 · ownership.direct: Nirland Limited, a company registered in Guernsey with company number 58804 of The Old Stables Rue a L'Or, St Peter Port, GUERNSEY GY1 1QG ("Nirland Limited") is wholly owned by Stockton Limited, a company registered in Guernsey ("Stockton Limited"), which is wholly owned by The Rowland Master Trust, a Guernsey trust ("The Rowland Master Trust"). Dovet Limited, a company registered in Guernsey ("Dovet Limited"), is the sole trustee of The Rowland Master Trust. By virtue of these relationships, each of Stockton Limited, The Rowland Master Trust and Dovet Limited may be deemed to share beneficial ownership of the securities held of record by Nirland Limited.

SEC source: 0001213900-24-086022 · ownership.xml · nonDerivative · entry 2

Nirland Ltd · CIK 0001994188 · 10% owner

Stockton Ltd · CIK 0001994176 · 10% owner

Rowland Master Trust · CIK 0001994314 · 10% owner

Dovet Ltd · CIK 0001994209 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,031,009

F1 · ownership.direct: Nirland Limited, a company registered in Guernsey with company number 58804 of The Old Stables Rue a L'Or, St Peter Port, GUERNSEY GY1 1QG ("Nirland Limited") is wholly owned by Stockton Limited, a company registered in Guernsey ("Stockton Limited"), which is wholly owned by The Rowland Master Trust, a Guernsey trust ("The Rowland Master Trust"). Dovet Limited, a company registered in Guernsey ("Dovet Limited"), is the sole trustee of The Rowland Master Trust. By virtue of these relationships, each of Stockton Limited, The Rowland Master Trust and Dovet Limited may be deemed to share beneficial ownership of the securities held of record by Nirland Limited.

SEC source: 0001213900-24-086022 · ownership.xml · nonDerivative · entry 1

Nirland Ltd · CIK 0001994188 · 10% owner

Stockton Ltd · CIK 0001994176 · 10% owner

Rowland Master Trust · CIK 0001994314 · 10% owner

Dovet Ltd · CIK 0001994209 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,400,000

F1 · ownership.direct: Nirland Limited, a company registered in Guernsey with company number 58804 of The Old Stables Rue a L'Or, St Peter Port, GUERNSEY GY1 1QG ("Nirland Limited") is wholly owned by Stockton Limited, a company registered in Guernsey ("Stockton Limited"), which is wholly owned by The Rowland Master Trust, a Guernsey trust ("The Rowland Master Trust"). Dovet Limited, a company registered in Guernsey ("Dovet Limited"), is the sole trustee of The Rowland Master Trust. By virtue of these relationships, each of Stockton Limited, The Rowland Master Trust and Dovet Limited may be deemed to share beneficial ownership of the securities held of record by Nirland Limited.

SEC source: 0001213900-24-084702 · ownership.xml · nonDerivative · entry 3

Nirland Ltd · CIK 0001994188 · 10% owner

Stockton Ltd · CIK 0001994176 · 10% owner

Rowland Master Trust · CIK 0001994314 · 10% owner

Dovet Ltd · CIK 0001994209 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,900,000

F1 · ownership.direct: Nirland Limited, a company registered in Guernsey with company number 58804 of The Old Stables Rue a L'Or, St Peter Port, GUERNSEY GY1 1QG ("Nirland Limited") is wholly owned by Stockton Limited, a company registered in Guernsey ("Stockton Limited"), which is wholly owned by The Rowland Master Trust, a Guernsey trust ("The Rowland Master Trust"). Dovet Limited, a company registered in Guernsey ("Dovet Limited"), is the sole trustee of The Rowland Master Trust. By virtue of these relationships, each of Stockton Limited, The Rowland Master Trust and Dovet Limited may be deemed to share beneficial ownership of the securities held of record by Nirland Limited.

SEC source: 0001213900-24-084702 · ownership.xml · nonDerivative · entry 2

Nirland Ltd · CIK 0001994188 · 10% owner

Stockton Ltd · CIK 0001994176 · 10% owner

Rowland Master Trust · CIK 0001994314 · 10% owner

Dovet Ltd · CIK 0001994209 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,233,177

F1 · ownership.direct: Nirland Limited, a company registered in Guernsey with company number 58804 of The Old Stables Rue a L'Or, St Peter Port, GUERNSEY GY1 1QG ("Nirland Limited") is wholly owned by Stockton Limited, a company registered in Guernsey ("Stockton Limited"), which is wholly owned by The Rowland Master Trust, a Guernsey trust ("The Rowland Master Trust"). Dovet Limited, a company registered in Guernsey ("Dovet Limited"), is the sole trustee of The Rowland Master Trust. By virtue of these relationships, each of Stockton Limited, The Rowland Master Trust and Dovet Limited may be deemed to share beneficial ownership of the securities held of record by Nirland Limited.

SEC source: 0001213900-24-084702 · ownership.xml · nonDerivative · entry 1

Nirland Ltd · CIK 0001994188 · 10% owner

Stockton Ltd · CIK 0001994176 · 10% owner

Rowland Master Trust · CIK 0001994314 · 10% owner

Dovet Ltd · CIK 0001994209 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,483,177

F1 · ownership.direct: Nirland Limited, a company registered in Guernsey with company number 58804 of The Old Stables Rue a L'Or, St Peter Port, GUERNSEY GY1 1QG ("Nirland Limited") is wholly owned by Stockton Limited, a company registered in Guernsey ("Stockton Limited"), which is wholly owned by The Rowland Master Trust, a Guernsey trust ("The Rowland Master Trust"). Dovet Limited, a company registered in Guernsey ("Dovet Limited"), is the sole trustee of The Rowland Master Trust. By virtue of these relationships, each of Stockton Limited, The Rowland Master Trust and Dovet Limited may be deemed to share beneficial ownership of the securities held of record by Nirland Limited.

SEC source: 0001493152-24-037150 · ownership.xml · nonDerivative · entry 12

Regan Andrew · CIK 0001991325 · Director · 10% owner

Corvus Capital Ltd. · CIK 0001990829 · 10% owner

Algo Holdings, Inc. · CIK 0001991236 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 177,627

F11 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.255-0.265, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares of Common Stock sold at each separate price within the range. Following the sales of shares of Common Stock as reported in this Form 4, Algo no longer holds 10% of the outstanding shares of Common Stock of the Issuer.

F2 · ownership.nature: Dr. Regan is the Chief Executive Officer and sole shareholder of Corvus. Algo is a wholly owned subsidiary of Corvus. By virtue of these relationships, Dr. Regan may be deemed to beneficially own the shares of Common Stock held of record by each of Corvus and Algo. Dr. Regan disclaims any such beneficial ownership except to the extent of his pecuniary interest therein.

F3 · ownership.nature: The securities are owned solely by Algo. On March 26, 2024, Algo pledged certain shares of Common Stock to a financial institution as collateral for a loan, pursuant to that certain Control and Restricted Loan Agreement, dated March 26, 2024, by and between Algo and such financial institution (the "Loan Agreement"). The loan proceeds were used to pay a portion of certain amounts due to a third party investor in the Issuer as an inducement to such investment to the Issuer in September 2023, pursuant to an agreement entered into by and among Algo, Corvus and such third party. These shares of Common Stock were sold by such financial institution pursuant to the terms and conditions of the Loan Agreement.